Apr 2026 - ASX-listed Archer Materials (AXE) progresses Biochip development, focusing on beta prototype and clinical trial preparation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results